TGAオーストラリア供給不足情報（2025年2月24日～3月2日）

ホーム > 供給不足情報 > 海外医薬品不足状況 > オーストラリア > TGAオーストラリア供給不足情報（2025年2月24日～3月2日）
Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
gabapentinCapsule, hard300 mgAnticipatedAvailableManufacturing28/02/2025
chlorhexidine gluconateSolution, irrigation30 mgCurrentLimited AvailabilityManufacturing28/02/2025
risedronate sodiumTablet, film coated35 mgCurrentLimited AvailabilityManufacturing28/02/2025
midazolamInjection, solution5 mgResolvedAvailableManufacturing28/02/2025
midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing28/02/2025
naproxenOral Liquid, suspension25 mg/mLAnticipatedAvailableManufacturing28/02/2025
trandolaprilCapsule, hard1 mgCurrentUnavailableManufacturing28/02/2025
trandolaprilCapsule, hard2 mgCurrentUnavailableManufacturing28/02/2025
trandolaprilCapsule, hard4 mgCurrentUnavailableManufacturing28/02/2025
duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand28/02/2025
capecitabineTablet, film coated500 mgCurrentLimited AvailabilityUnexpected increase in consumer demand28/02/2025
bortezomibInjection, powder for3.5 mgResolvedAvailableManufacturing28/02/2025
pemetrexed disodiumInjection, powder for1102.9 mgAnticipatedAvailableManufacturing28/02/2025
clonidine hydrochlorideTablet100 microgramCurrentLimited AvailabilityUnexpected increase in consumer demand28/02/2025
hydrocortisoneTablet, uncoated20 mgCurrentLimited AvailabilityManufacturing28/02/2025
PegfilgrastimInjection, solution6 mgAnticipatedAvailableManufacturing28/02/2025
clobazamTablet, uncoated10 mgResolvedAvailableManufacturing28/02/2025
chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing28/02/2025
sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing28/02/2025
sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing28/02/2025
sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing28/02/2025
alprazolamTablet, uncoated2 mgAnticipatedAvailableManufacturing28/02/2025
metformin hydrochloride~sitagliptin hydrochloride monohydrateTablet, film coated500 mg~56.69 mgCurrentUnavailableManufacturing28/02/2025
metformin hydrochloride~sitagliptin hydrochloride monohydrateTablet, film coated850 mg~56.69 mgCurrentUnavailableManufacturing28/02/2025
nizatidineCapsule150 mgAnticipatedAvailableManufacturing28/02/2025
ramiprilCapsule, hard1.25 mgResolvedAvailableManufacturing27/02/2025
fentanylDrug delivery system, transdermal16.8 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply27/02/2025
mycophenolate mofetilTablet, film coated500 mgCurrentUnavailableManufacturing27/02/2025
acetylcysteineInjection, concentrated2 gCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply27/02/2025
ropivacaine hydrochlorideInjection, solution2 mg/mLCurrentUnavailableCommercial Changes / Commercial viability27/02/2025
risperidoneTablet, film coated1 mgCurrentUnavailableUnexpected increase in consumer demand27/02/2025
risperidoneTablet, film coated2 mgResolvedAvailableUnexpected increase in consumer demand27/02/2025
phenoxymethylpenicillin potassiumTablet, film coated280 mgAnticipatedAvailableManufacturing27/02/2025
paroxetine hydrochlorideTablet, film coated22.21 mgResolvedAvailableManufacturing27/02/2025
atomoxetine hydrochlorideCapsule, hard45.72 mgCurrentUnavailableManufacturing27/02/2025
atomoxetine hydrochlorideCapsule, hard91.44 mgCurrentUnavailableManufacturing27/02/2025
isotretinoinCapsule, soft10 mgResolvedAvailableManufacturing27/02/2025
esomeprazoleCapsule, enteric40 mgResolvedAvailableManufacturing27/02/2025
anastrozoleTablet, film coated1 mgCurrentUnavailableManufacturing27/02/2025
celecoxibCapsule, hard100 mgCurrentUnavailableManufacturing27/02/2025
irinotecan hydrochloride trihydrateInjection, concentrated500 mgAnticipatedAvailableManufacturing27/02/2025
azithromycin dihydrateTablet, film coated524 mgCurrentUnavailableUnexpected increase in consumer demand27/02/2025
ropivacaine hydrochlorideInjection, solution2 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability27/02/2025
midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand27/02/2025
metformin hydrochlorideTablet, film coated1000 mgCurrentUnavailableManufacturing27/02/2025
citalopram hydrobromideTablet, film coated49.96 mgCurrentLimited AvailabilityManufacturing27/02/2025
lincomycin hydrochloride monohydrateInjection, solution340.26 mg/mLCurrentUnavailableManufacturing26/02/2025
glycopyrronium bromideInjection, solution.2 mg/mLCurrentLimited AvailabilityManufacturing26/02/2025
chloramphenicolEye Drops5 mg/mLCurrentUnavailableManufacturing26/02/2025
levothyroxine sodiumTablet200 microgramCurrentUnavailableManufacturing26/02/2025
midazolamInjection, solution15 mgAnticipatedAvailableManufacturing26/02/2025
fluticasone propionate~salmeterol xinafoateInhalation, powder for100 microgram/actuation~72.5 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand26/02/2025
fluorouracilInjection, solution50 mg/mLCurrentUnavailableManufacturing26/02/2025
dosulepin (dothiepin) hydrochlorideTablet, film coated75 mgCurrentLimited AvailabilityManufacturing26/02/2025
daptomycinInjection, powder for350 mgDiscontinuedUnavailableCommercial Changes / Commercial viability26/02/2025
buprenorphinePatch, dermal30 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply26/02/2025
methotrexateTablet10 mgCurrentLimited AvailabilityManufacturing26/02/2025
metformin hydrochloride~sitagliptin hydrochloride monohydrateTablet, modified release1000 mg~113.37 mgCurrentUnavailableManufacturing26/02/2025
fluorouracilInjection, solution50 mg/mLCurrentUnavailableManufacturing26/02/2025
lidocaine hydrochlorideInjection, solution10 mg/mLCurrentUnavailableManufacturing26/02/2025
lidocaine hydrochlorideInjection, solution10 mg/mLCurrentUnavailableManufacturing25/02/2025
adrenaline (epinephrine) acid tartrate~lidocaine hydrochlorideInjection, solution9.1 microgram/mL~10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability25/02/2025
pentetic acidInjection, powder for5 mgCurrentUnavailableManufacturing25/02/2025
medronic acidInjection, powder for10 mgCurrentUnavailableManufacturing25/02/2025
sodium fluorideInjection, concentrated1 mg/mLCurrentUnavailableManufacturing25/02/2025
atropine sulfate monohydrateEye Drops, solution9.9737 mg/mLCurrentUnavailableManufacturing25/02/2025
rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrentUnavailableManufacturing25/02/2025
ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgCurrentUnavailableManufacturing25/02/2025
oxytocinInjection, solution5 IU/mLCurrentLimited AvailabilityUnexpected increase in consumer demand25/02/2025
carboplatinInjection, solution450 mgCurrentUnavailableManufacturing25/02/2025
acarboseTablet100 mgCurrentLimited AvailabilityManufacturing25/02/2025
acarboseTablet50 mgCurrentUnavailableManufacturing25/02/2025
acarboseTablet50 mgDiscontinuedUnavailableCommercial Changes / Commercial viability25/02/2025
acarboseTablet100 mgDiscontinuedUnavailableCommercial Changes / Commercial viability25/02/2025
ezetimibeTablet, uncoated10 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply25/02/2025
cisplatinInjection, concentrated1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand25/02/2025
ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgCurrentUnavailableManufacturing25/02/2025
atorvastatin calcium trihydrate~ezetimibeTablet, film coated20.681 mg~10 mgCurrentUnavailableManufacturing25/02/2025
atorvastatin calcium trihydrate~ezetimibeTablet, film coated82.725 mg~10 mgCurrentUnavailableManufacturing25/02/2025
mupirocin calciumCream21.5 mg/gCurrentUnavailableManufacturing25/02/2025
indometacinCapsule, hard25 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply25/02/2025
clonidine hydrochlorideTablet, uncoated150 microgramCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues25/02/2025
sodium pyrophosphateInjection, powder for30 mgCurrentUnavailableManufacturing24/02/2025
duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply24/02/2025
ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.583 mgCurrentUnavailableManufacturing24/02/2025
ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentUnavailableManufacturing24/02/2025
ezetimibe~atorvastatin calcium trihydrateTablet, multilayer10 mg~21.7 mgResolvedAvailableManufacturing24/02/2025
olmesartan medoxomilTablet, film coated40 mgCurrentLimited AvailabilityManufacturing24/02/2025
tacrolimus monohydrateCapsule.767 mgCurrentLimited AvailabilityManufacturing24/02/2025
amiodarone hydrochlorideInjection, solution150 mgCurrentLimited AvailabilityManufacturing24/02/2025
azithromycin dihydrateTablet, film coated524 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues24/02/2025
nebivolol hydrochlorideTablet10.9 mgResolvedAvailableManufacturing24/02/2025
escitalopram oxalateTablet, film coated12.74 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability24/02/2025
naloxone hydrochloride dihydrateSpray, nasal2.2 mg/actuationCurrentLimited AvailabilityUnexpected increase in consumer demand24/02/2025
nebivolol hydrochlorideTablet1.363 mgResolvedAvailableManufacturing24/02/2025
nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing24/02/2025
2025年3月3日
このページの先頭へ戻る